101 related articles for article (PubMed ID: 10673852)
1. [Current diagnostic method, prognosis estimation and therapy of papillary thyroid cancer: recommendations of the medical universities and the National Oncologic Institute of Budapest].
Esik O; Balázs C; Boér A; Csernay L; Földes J; Füzy M; Horváth OP; Julesz J; Kásler M; Laczi F; Leövey A; Lukács G; Németh G; Perner F; Repa I; Szabolcs I; Szentirmay Z; Trón L; Balázs G
Orv Hetil; 2000 Jan; 141(1):5-16. PubMed ID: 10673852
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
3. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
4. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
5. Followup of patients with papillary thyroid cancer: in search of the optimal algorithm.
Mittendorf EA; Wang X; Perrier ND; Francis AM; Edeiken BS; Shapiro SE; Lee JE; Evans DB
J Am Coll Surg; 2007 Aug; 205(2):239-47. PubMed ID: 17660070
[TBL] [Abstract][Full Text] [Related]
6. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
8. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
9. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
10. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
11. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
12. [Juvenile aneuploid papillary cancer of the thyroid with pulmonary metastasis].
Lengyel E; Somogyi A; Molnár T; Tóth E; Remenár E; Skriba Z; Esik O
Orv Hetil; 1998 Mar; 139(12):687-90. PubMed ID: 9555165
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
14. Lymph node dissection in papillary or follicular thyroid carcinoma.
Bononi M; Tocchi A; Cangemi V; Vecchione A; Giovagnoli MR; De Cesare A; Fiori E; Volpino P; Brozzetti S; Meucci M; Scozzafava S; Cavallaro A
Anticancer Res; 2004; 24(4):2439-42. PubMed ID: 15330196
[TBL] [Abstract][Full Text] [Related]
15. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
17. [Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].
Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
Orv Hetil; 1996 May; 137(20):1067-78. PubMed ID: 8657418
[TBL] [Abstract][Full Text] [Related]
18. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
Mathonnet M
Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
[TBL] [Abstract][Full Text] [Related]
19. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique.
Grodski S; Cornford L; Sywak M; Sidhu S; Delbridge L
ANZ J Surg; 2007 Apr; 77(4):203-8. PubMed ID: 17388820
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
Włoch J; Czarniecka A; Turska M; Wilgus J
Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]